GAS-CHROMATOGRAPHY MASS-SPECTROMETRY VALIDATION OF HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY ANALYSIS OF FLECAINIDE ENANTIOMERS IN SERUM

被引:2
作者
FISCHER, C
BUHL, K
机构
关键词
D O I
10.1097/00007691-199210000-00015
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:433 / 435
页数:3
相关论文
共 22 条
[1]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF THE ENANTIOMERS OF FLECAINIDE IN HUMAN PLASMA AND URINE [J].
ALESSISEVERINI, S ;
JAMALI, F ;
PASUTTO, FM ;
COUTTS, RT ;
GULAMHUSEIN, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1990, 79 (03) :257-260
[2]  
ALESSISEVERINI S, 1991, CLIN CHEM, V37, P111
[3]   ORAL FLECAINIDE ACETATE FOR THE TREATMENT OF VENTRICULAR ARRHYTHMIAS [J].
ANDERSON, JL ;
STEWART, JR ;
PERRY, BA ;
VANHAMERSVELD, DD ;
JOHNSON, TA ;
CONARD, GJ ;
CHANG, SF ;
KVAM, DC ;
PITT, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (09) :473-477
[4]  
[Anonymous], 1989, NEW ENGL J MED, V321, P406
[5]   RESOLUTION OF FLECAINIDE ACETATE, N-(2-PIPERIDYLMETHYL)-2,5-BIS(2,2,2-TRIFLUOROETHOXY)BENZAMIDE ACETATE, AND ANTIARRHYTHMIC PROPERTIES OF THE ENANTIOMERS [J].
BANITT, EH ;
SCHMID, JR ;
NEWMARK, RA .
JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (02) :299-302
[6]   FLECAINIDE HALF-LIFE PROLONGATION IN 2 PATIENTS WITH CONGESTIVE HEART-FAILURE AND COMPLEX VENTRICULAR ARRHYTHMIAS [J].
CAVALLI, A ;
MAGGIONI, AP ;
MARCHI, S ;
VOLPI, A ;
LATINI, R .
CLINICAL PHARMACOKINETICS, 1988, 14 (03) :187-188
[7]  
EICHELBAUM M, 1988, ISI ATLAS-PHARMACOL, V2, P243
[8]   DETERMINATION OF THE ENANTIOMERS OF FLECAINIDE AND 2 MAJOR METABOLITES IN MAN BY GAS-CHROMATOGRAPHY MASS-SPECTROMETRY USING NEGATIVE-ION CHEMICAL IONIZATION AND STABLE ISOTOPE LABELED INTERNAL STANDARDS [J].
FISCHER, C ;
SCHONBERGER, F ;
MEESE, CO ;
EICHELBAUM, M .
BIOMEDICAL AND ENVIRONMENTAL MASS SPECTROMETRY, 1990, 19 (04) :256-266
[9]   ORAL FLECAINIDE PHARMACOKINETICS IN PATIENTS WITH IMPAIRED RENAL-FUNCTION [J].
FORLAND, SC ;
BURGESS, E ;
BLAIR, AD ;
CUTLER, RE ;
KVAM, DC ;
WEEKS, CE ;
FOX, JM ;
CONARD, GJ .
JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 28 (03) :259-267
[10]   STEREOSELECTIVE DISPOSITION OF FLECAINIDE IN RELATION TO THE SPARTEINE DEBRISOQUINE METABOLIZER PHENOTYPE [J].
GROSS, AS ;
MIKUS, G ;
FISCHER, C ;
HERTRAMPF, R ;
GUNDERTREMY, U ;
EICHELBAUM, M .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 28 (05) :555-566